Atlas Trials

Study Evaluating the Efficacy and Safety of Pantoprazole in Infants With Symptomatic Gastroesophageal Reflux Disease (GERD)

Clinical trial NCT00365300 · COMPLETED

Trial details

NCT number
NCT00365300
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Gastroesophageal Reflux
Start date
2006-09-01
Primary completion
2007-11-01
Enrollment
129

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.